{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:59:22Z","timestamp":1772157562678,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004955","name":"Austrian Research Promotion Agency","doi-asserted-by":"publisher","award":["877143"],"award-info":[{"award-number":["877143"]}],"id":[{"id":"10.13039\/501100004955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006012","name":"Christian Doppler Research Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omton.2025.201072","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T07:30:02Z","timestamp":1761377402000},"page":"201072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Newly identified oncolytic VSV-GP-specific CD8+ T cell epitopes for monitoring of anti-viral immune responses in the BALB\/c mouse model"],"prefix":"10.1016","volume":"33","author":[{"given":"Sarah","family":"Danklmaier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia V.","family":"Vijver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Pipperger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Floriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Perro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Hackl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9894-842X","authenticated-orcid":false,"given":"Guido","family":"Wollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.201072_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro1927","article-title":"Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded","volume":"6","author":"Cattaneo","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.omton.2025.201072_bib2","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1158\/0008-5472.CAN-13-3306","article-title":"Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency","volume":"74","author":"Muik","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201072_bib3","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/ijc.31556","article-title":"Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer","volume":"143","author":"Urbiola","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omton.2025.201072_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/v10030108","article-title":"The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma","volume":"10","author":"Kimpel","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2025.201072_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41416-019-0574-7","article-title":"The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer","volume":"121","author":"Schreiber","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2025.201072_bib6","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1038\/s41467-021-25506-6","article-title":"A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity","volume":"12","author":"Das","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201072_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236107","article-title":"Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect","volume":"13","author":"Hofer","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2025.201072_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164178","article-title":"Oncolytic Viruses and Immune Checkpoint Inhibitors: The \"Hot\" New Power Couple","volume":"15","author":"Lovatt","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2025.201072_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12080867","article-title":"Characterization of the Anti-Viral and Vaccine-Specific CD8(+) T Cell Composition upon Treatment with the Cancer Vaccine VSV-GP","volume":"12","author":"Hofer","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.omton.2025.201072_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.omtm.2020.01.001","article-title":"Oncolytic Viruses and the Immune System: The Dynamic Duo","volume":"17","author":"Lemos de Matos","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2025.201072_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.it.2017.11.006","article-title":"Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies","volume":"39","author":"Gujar","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molimm.2021.05.009","article-title":"Playing hide and seek: Tumor cells in control of MHC class I antigen presentation","volume":"136","author":"Jongsma","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2680160","article-title":"Fundamentals and Methods for T- and B-Cell Epitope Prediction","volume":"2017","author":"Sanchez-Trincado","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.omton.2025.201072_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci."},{"key":"10.1016\/j.omton.2025.201072_bib16","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3389\/fimmu.2018.01716","article-title":"Predicting Antigen Presentation-What Could We Learn From a Million Peptides?","volume":"9","author":"Gfeller","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib17","article-title":"Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP","volume":"13","author":"Vijver","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/300231a0","article-title":"Identification of the class I genes of the mouse major histocompatibility complex by DNA-mediated gene transfer","volume":"300","author":"Goodenow","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.201072_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fonc.2020.00475","article-title":"Delivery and Biosafety of Oncolytic Virotherapy","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2025.201072_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122857","article-title":"Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer","volume":"3","author":"Kinkead","year":"2018","journal-title":"JCI insight"},{"key":"10.1016\/j.omton.2025.201072_bib21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3389\/fcell.2020.00728","article-title":"Progress in Neoantigen Targeted Cancer Immunotherapies","volume":"8","author":"Han","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omton.2025.201072_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.891524","article-title":"In Silico Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell Recognition","volume":"13","author":"Isaeva","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib23","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.3390\/cimb45100502","article-title":"Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2","volume":"45","author":"Erez","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.omton.2025.201072_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1127470","article-title":"Antigen-specificity measurements are the key to understanding T cell responses","volume":"14","author":"Tippalagama","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2051013614525375","article-title":"MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines","volume":"2","author":"Comber","year":"2014","journal-title":"Ther. Adv. Vaccines"},{"key":"10.1016\/j.omton.2025.201072_bib26","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1042\/BST20210410","article-title":"The pockets guide to HLA class I molecules","volume":"49","author":"Nguyen","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.omton.2025.201072_bib27","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1074\/jbc.M510511200","article-title":"Structural definition of the H-2Kd peptide-binding motif","volume":"281","author":"Mitaksov","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.201072_bib28","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1073\/pnas.94.13.6880","article-title":"The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide","volume":"94","author":"Balendiran","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.201072_bib29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00172063","article-title":"MHC ligands and peptide motifs: first listing","volume":"41","author":"Rammensee","year":"1995","journal-title":"Immunogenetics"},{"key":"10.1016\/j.omton.2025.201072_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/351290a0","article-title":"Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules","volume":"351","author":"Falk","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.201072_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/eji.200526235","article-title":"Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells","volume":"36","author":"Suri","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/jmbi.1998.2091","article-title":"Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120","volume":"283","author":"Li","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.omton.2025.201072_bib33","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.4049\/jimmunol.178.10.6350","article-title":"Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent","volume":"178","author":"Ramsburg","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/cgt.2011.81","article-title":"Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity","volume":"19","author":"Stephenson","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omton.2025.201072_bib35","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.4049\/jimmunol.180.11.7193","article-title":"Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve","volume":"180","author":"Oseroff","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.111995","article-title":"Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants","volume":"42","author":"Meyer","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2025.201072_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2008.08.001","article-title":"Selection for gene junction sequences important for VSV transcription","volume":"380","author":"Hinzman","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.omton.2025.201072_bib38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/v14030521","article-title":"The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid","volume":"14","author":"\u0160antak","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2025.201072_bib39","doi-asserted-by":"crossref","first-page":"E7578","DOI":"10.1073\/pnas.1806200115","article-title":"Analysis of CD8(+) T cell response during the 2013-2016 Ebola epidemic in West Africa","volume":"115","author":"Sakabe","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.201072_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-065X.1991.tb00607.x","article-title":"Heterogeneity in lymphokine profiles of CD4+ and CD8+ T cells and clones activated in vivo and in vitro","volume":"123","author":"Kelso","year":"1991","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omton.2025.201072_bib41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ni1559","article-title":"T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation","volume":"9","author":"Henrickson","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib42","article-title":"Mapping and role of T cell response in SARS-CoV-2-infected mice","volume":"218","author":"Zhuang","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2025.201072_bib43","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2025.201072_bib44","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14707","article-title":"HLA-A\u221701:01 allele diminishing in COVID-19 patients population associated with non-structural epitope abundance in CD8+ T-cell repertoire","volume":"11","author":"Shkurnikov","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.omton.2025.201072_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ni.2169","article-title":"Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus","volume":"13","author":"Honke","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003650","article-title":"Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes","volume":"9","author":"Honke","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omton.2025.201072_bib47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.omtm.2022.12.013","article-title":"Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication","volume":"28","author":"Dambra","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2025.201072_bib48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/gt.2009.1","article-title":"Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob","volume":"16","author":"Nishimoto","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.omton.2025.201072_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001586","article-title":"Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory","volume":"9","author":"Hinterberger","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2025.201072_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2006.04.017","article-title":"Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming","volume":"25","author":"Allan","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.201072_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004464","article-title":"Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy","volume":"10","author":"Groeneveldt","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2025.201072_bib52","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.2217\/fon-2022-0439","article-title":"Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors","volume":"18","author":"Porosnicu","year":"2022","journal-title":"Future Oncol."},{"key":"10.1016\/j.omton.2025.201072_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2020.05.004","article-title":"Effects of tumor necrosis factor on viral replication and pulmonary inflammation during acute mouse adenovirus type 1 respiratory infection","volume":"547","author":"Pant","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.omton.2025.201072_bib54","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/JVI.79.1.202-213.2005","article-title":"Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection","volume":"79","author":"Suresh","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.201072_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/tan.13789","article-title":"Peptide-MHC class I and class II tetramers: From flow to mass cytometry","volume":"95","author":"Christophersen","year":"2020","journal-title":"Hla"},{"key":"10.1016\/j.omton.2025.201072_bib56","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1073\/pnas.181348898","article-title":"Discrepancy between ELISPOT IFN-gamma secretion and binding of A2\/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide\/MHC complexes half-life","volume":"98","author":"Rubio-Godoy","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.201072_bib57","doi-asserted-by":"crossref","first-page":"23799","DOI":"10.1074\/jbc.M700976200","article-title":"Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties","volume":"282","author":"Laugel","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.201072_bib58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1074-7613(00)80169-7","article-title":"Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism","volume":"12","author":"San Jos\u00e9","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.201072_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2008.09.014","article-title":"Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers","volume":"340","author":"Lissina","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.omton.2025.201072_bib60","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4049\/jimmunol.1700242","article-title":"Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations","volume":"200","author":"Rius","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.201072_bib61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0167-4781(02)00462-1","article-title":"Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus","volume":"1577","author":"Barr","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omton.2025.201072_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","article-title":"Determination of 50% endpoint titer using a simple formula","volume":"5","author":"Ramakrishnan","year":"2016","journal-title":"World J. Virol."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:19:31Z","timestamp":1772155171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925001419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2950329925001419"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.201072","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newly identified oncolytic VSV-GP-specific CD8+ T cell epitopes for monitoring of anti-viral immune responses in the BALB\/c mouse model","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.201072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201072"}}